Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 20/20 | 1.00 |
| ▸ | TBXA2R | P21731 | 4/20 | 0.77 |
| ▸ | PTGDR | Q13258 | 4/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.70 |
| ▸ | PTGIR | P43119 | 2/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL142820 | 0.96 | PTGDR2 (0.93) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL136971 | 0.96 | PTGDR2 (0.93) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL151535 | 0.94 | PTGDR2 (0.88) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL150210 | 0.92 | PTGDR2 (0.85) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL29402580 | 0.92 | PTGDR2 (0.85) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL253825 | 0.92 | PTGDR2 (0.85) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL13746086 | 0.92 | PTGDR2 (0.84) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL154283 | 0.90 | PTGDR2 (0.82) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL142814 | 0.89 | PTGDR2 (0.80) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL135003 | 0.89 | PTGDR2 (0.80) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2912458-B1 | NON-INVASIVE BIOMARKER TO IDENTIFY SUBJECTS AT RISK OF PRETERM DELIVERY | NYU WINTHROP HOSPITAL (US) | 2018-07-18 | — | — | EP | claimed |
| US-9797903-B2 | Non-invasive biomarker to identify subject at risk of preterm delivery | WINTHROP-UNIVERSITY HOSPITAL (US) | 2017-10-24 | — | — | US | claimed |
| EP-2257524-B1 | N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS | BRICKELL BIOTECH INC (US) | 2016-01-06 | — | — | EP | claimed |
| US-20150285800-A1 | NON-INVASIVE BIOMARKER TO IDENTIFY SUBJECT AT RISK OF PRETERM DELIVERY | NYU WINTHROP HOSPITAL | 2015-10-08 | — | — | US | claimed |
| EP-2912458-A1 | NON-INVASIVE BIOMARKER TO IDENTIFY SUBJECTS AT RISK OF PRETERM DELIVERY | Winthrop-University Hospital (US) | 2015-09-02 | — | — | EP | claimed |
| WO-2014066568-A1 | NON-INVASIVE BIOMARKER TO IDENTIFY SUBJECTS AT RISK OF PRETERM DELIVERY | WINTHROP-UNIVERSITY HOSPITAL (US) | 2014-05-01 | — | — | WO | claimed |
| US-8362044-B2 | N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors | PANMIRA PHARMACEUTICALS, LLC (US) | 2013-01-29 | — | — | US | claimed |
| EP-2480225-A2 | DERMAL FORMULATIONS OF DP2 RECEPTOR ANTAGONISTS | Panmira Pharmaceuticals, LLC (US) | 2012-08-01 | — | — | EP | claimed |
| US-20120184493-A1 | DERMAL FORMULATIONS OF DP2 RECEPTOR ANTAGONISTS | PANMIRA PHARMACEEUTICALS, LLC (US) | 2012-07-19 | — | — | US | claimed |
| EP-2461809-A2 | OPHTHALMIC PHARMACEUTICAL COMPOSITIONS OF DP2 RECEPTOR ANTAGONISTS | Panmira Pharmaceuticals, LLC (US) | 2012-06-13 | — | — | EP | claimed |
| US-20120058123-A1 | N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS | PANMIRA PHARMACEUTICALS, LLC. (US) | 2012-03-08 | — | — | US | claimed |
| US-20120059055-A1 | N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS | PANMIRA PHARMACEUTICALS, LLC (US) | 2012-03-08 | — | — | US | claimed |
| US-8067445-B2 | N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors | PANMIRA PHARMACEUTICALS, LLC (US) | 2011-11-29 | — | — | US | claimed |
| US-20110098352-A1 | N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS | AMIRA PHARMACEUTICALS, INC. (US) | 2011-04-28 | — | — | US | claimed |
| US-20110039852-A1 | N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS | AMIRA PHARMACEUTICALS, INC. (US) | 2011-02-17 | — | — | US | claimed |
| WO-2011014587-A2 | OPHTHALMIC PHARMACEUTICAL COMPOSITIONS OF DP2 RECEPTOR ANTAGONISTS | AMIRA PHARMACEUTICALS, INC. (US) | 2011-02-03 | — | — | WO | claimed |
| WO-2011014588-A2 | DERMAL FORMULATIONS OF DP2 RECEPTOR ANTAGONISTS | AMIRA PHARMACEUTICALS, INC. (US) | 2011-02-03 | — | — | WO | claimed |
| EP-2245002-A1 | N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS | Amira Pharmaceuticals, Inc. (US) | 2010-11-03 | — | — | EP | claimed |
| WO-2009099901-A1 | N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS | AMIRA PHARMACEUTICALS, INC. (US) | 2009-08-13 | — | — | WO | claimed |
| US-20090197959-A1 | N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS | AMIRA PHARMACEUTICALS, INC. (US) | 2009-08-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110039852-A1 | N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS | PTGDR, PTGDR2, PTGER2 | PTGDR2 2/4885TBXA2R 12/4885PTGDR 1/4885 |
| US-20120058123-A1 | N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS | PTGDR, PTGDR2, PTGER2 | PTGDR2 2/4885TBXA2R 12/4885PTGDR 1/4885 |
| US-20110098352-A1 | N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS | PTGDR, PTGDR2, PTGIR | PTGDR2 2/4885TBXA2R 6/4885PTGDR 1/4885 |
| US-20090197959-A1 | N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS | PTGDR, PTGDR2, PTGIR | PTGDR2 2/4885TBXA2R 6/4885PTGDR 1/4885 |
| US-20120184493-A1 | DERMAL FORMULATIONS OF DP2 RECEPTOR ANTAGONISTS | BDKRB2, TRPV2, CYSLTR2 | PTGDR2 14/4885TBXA2R 7/4885PTGDR 29/4885 |
| US-20120059055-A1 | N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS | PTGDR, PTGDR2, PTGIR | PTGDR2 2/4885TBXA2R 6/4885PTGDR 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.